Capobianco Ivan, Rolinger Jens, Nadalin Silvio
Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany.
Transl Gastroenterol Hepatol. 2018 Sep 18;3:69. doi: 10.21037/tgh.2018.09.01. eCollection 2018.
Klatskin's tumors, actually-redefined as perihilar cholangiocarcinoma (phCCA) do represent 50-70% of all CCAs and develop in a context of chronic inflammation and cholestasis of bile ducts. Surgical resection provides the only chance of cure for this disease but is technically challenging because of the complex, intimate and variable relationship between biliary and vascular structures at this location. Five years survival rates range between 25-45% (median 27-58 months) in case of R0 resection and 0-23% (median 12-21 months) in case of R1 resection respectively. It should be noted that the major costs of high radicality are represented by relative high morbidity and mortality rates (i.e., 20-66% and 0-9% respectively). Considering the fact that radical resection may represent the only curative treatment of phCCA, we focused our review on surgical planning and techniques that may improve resectability rates and outcomes for locally advanced phCCA. The surgical treatment of phCCA can be successful when following aspects have been fulfilled: (I) accurate preoperative diagnostic aimed to identify the tumor in all its details (localization and extension) and to study all the risk factors influencing a posthepatectomy liver failure (PHLF): i.e., liver volume, liver function, liver quality, haemodynamics and patient characteristics; (II) High end surgical skills taking in consideration the local extension of the tumor and the vascular invasion which usually require an extended hepatic resection and often a vascular resection; (III) adequate postoperative management aimed to avoid major complications (i.e., PHLF and biliary complications). These are technically challenging operations and must be performed in a high volume centres by hepato-biliary-pancreas (HBP)-surgeons with experience in microsurgical vascular techniques.
实际上,克氏壶腹周围癌(Klatskin's tumors)现被重新定义为肝门部胆管癌(perihilar cholangiocarcinoma,phCCA),占所有胆管癌的50%-70%,在胆管慢性炎症和胆汁淤积的背景下发生。手术切除是治愈该疾病的唯一机会,但由于该部位胆管和血管结构之间复杂、紧密且多变的关系,手术在技术上具有挑战性。R0切除的5年生存率分别在25%-45%(中位生存期27-58个月)之间,R1切除的5年生存率在0%-23%(中位生存期12-21个月)之间。需要注意的是,高根治性手术的主要代价是相对较高的发病率和死亡率(分别为20%-66%和0%-9%)。鉴于根治性切除可能是phCCA唯一的治愈性治疗方法,我们的综述重点关注可能提高局部晚期phCCA可切除率和治疗效果的手术规划和技术。当满足以下方面时,phCCA的手术治疗可能会成功:(I)准确的术前诊断,旨在详细识别肿瘤(定位和范围),并研究所有影响肝切除术后肝衰竭(PHLF)的危险因素,即肝脏体积、肝功能、肝脏质量、血流动力学和患者特征;(II)高超的手术技巧,考虑到肿瘤的局部范围和血管侵犯,这通常需要扩大肝切除,且常常需要血管切除;(III)充分的术后管理,旨在避免主要并发症(即PHLF和胆道并发症)。这些手术在技术上具有挑战性,必须由具有显微外科血管技术经验的肝-胆-胰(HBP)外科医生在大容量中心进行。